| My Account | Subscribe | Contact Us | Donate |
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Insulin Articles
A report published in the August 1992 issue of Diabetes Care predicts that the early morning high blood sugars (hyperglycemia) experienced by Type I diabetes patients could possibly be the result of their current insulin therapy. With a twice-daily dosage of combined human lente and regular insulin (HL/R) injections, blood sugar levels may rise from a lack of insulin early in the morning, when it is needed most.
Researchers from the Department of Pediatrics and Medicine at the Indiana University Medical Center, Indianapolis, compared the effects of human ultralente insulin (HUL) and human lente insulin on morning fasting blood glucose levels. The purpose of the study was to determine whether a twice-daily regimen of human ultralente insulin combined with regular insulin (HUL/R) would improve raised morning blood sugar levels and metabolic control in children with Type I diabetes.
The researchers developed a twice-daily injection regimen using HUL insulin in their study. The authors of the report note that since HUL insulin has a longer duration and a diminished peak, it would increase the amount of insulin available in the early morning hours.
Thirty-one children with Type I diabetes were selected to carry out the study. After continuing the patients on four more weeks of HL/R injections, the researchers split the group into HUL/R insulin users and HL/R insulin users. The trial lasted for twelve weeks, with each patient taking an injection once before breakfast and once before the evening meal.
After the twelve week trial, the researchers concluded that young Type I diabetes patients using twice-daily doses of human ultralente (HUL) insulin combined with regular insulin can safely improve fasting blood glucose levels and lower the magnitude of the morning glucose rise. HUL/R did not improve metabolic control.
Categories: Insulin
Nov 1, 1992 - Not Yet Rated
Email to a Friend
Send a link to this page to your friends and colleagues.